{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T17:47:19Z","timestamp":1790790439685,"version":"4.1.0"},"reference-count":90,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,24]],"date-time":"2024-10-24T00:00:00Z","timestamp":1729728000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009687","name":"Uniwersytet Medyczny im. Piast\u00f3w Slaskich we Wroclawiu","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009687","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009647","name":"Ministry of Health","doi-asserted-by":"publisher","award":["SUBZ.C220.24.053"],"award-info":[{"award-number":["SUBZ.C220.24.053"]}],"id":[{"id":"10.13039\/100009647","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental and Molecular Pathology"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.yexmp.2024.104942","type":"journal-article","created":{"date-parts":[[2024,11,4]],"date-time":"2024-11-04T12:42:38Z","timestamp":1730724158000},"page":"104942","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Diagnostic criteria and therapeutic implications of rapid-onset demyelinating polyneuropathies"],"prefix":"10.1016","volume":"140","author":[{"given":"Wiktoria","family":"Ra\u0142owska-Gmoch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Koszewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beata","family":"\u0141abuz-Roszak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u0142awomir","family":"Budrewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edyta","family":"Dziadkowiak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.yexmp.2024.104942_bb0005","article-title":"A study of sensory nerve conduction in pre- and post-immunoglobulin treatment of Guillain-Barr\u00e9 Syndrome","volume":"16","author":"A","year":"2024","journal-title":"Cureus"},{"issue":"10","key":"10.1016\/j.yexmp.2024.104942_bb0010","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1177\/0883073820925302","article-title":"Papilledema in chronic inflammatory demyelinating Polyradiculoneuropathy (CIDP): A pediatric case and review of the literature","volume":"35","author":"Abrams","year":"2020","journal-title":"J. Child Neurol."},{"issue":"6","key":"10.1016\/j.yexmp.2024.104942_bb0015","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1097\/ICU.0000000000000611","article-title":"Update: the Miller Fisher variants of Guillain-Barr\u00e9 syndrome","volume":"30","author":"Al Othman","year":"2019","journal-title":"Curr. Opin. Ophthalmol."},{"issue":"3","key":"10.1016\/j.yexmp.2024.104942_bb0020","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/jns.12266","article-title":"Differences between acute-onset chronic inflammatory demyelinating polyneuropathy and acute inflammatory demyelinating polyneuropathy in adult patients","volume":"23","author":"Alessandro","year":"2018","journal-title":"J. Peripher. Nerv. Syst."},{"issue":"5","key":"10.1016\/j.yexmp.2024.104942_bb0025","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1590\/0004-282x-anp-2021-0226","article-title":"Treatment-related fluctuations in Guillain-Barr\u00e9 syndrome: clinical features and predictors of recurrence","volume":"80","author":"Alessandro","year":"2022","journal-title":"Arq. Neuropsiquiatr."},{"issue":"23","key":"10.1016\/j.yexmp.2024.104942_bb0030","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000207282","article-title":"CSF findings in relation to clinical characteristics, subtype, and disease course in patients with Guillain-Barr\u00e9 syndrome","volume":"100","author":"Al-Hakem","year":"2023","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.yexmp.2024.104942_bb0035","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s40120-020-00184-6","article-title":"The misdiagnosis of CIDP: A review","volume":"9","author":"Allen","year":"2020","journal-title":"Neurol. Ther."},{"issue":"6","key":"10.1016\/j.yexmp.2024.104942_bb0040","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1007\/s10072-012-1179-6","article-title":"Chronic inflammatory demyelinating polyradiculoneuropathy associated intracranial hypertension","volume":"34","author":"Altinkaya","year":"2013","journal-title":"Neurol. Sci."},{"issue":"3","key":"10.1016\/j.yexmp.2024.104942_bb0045","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1055\/s-0032-1329196","article-title":"Guillain-Barr\u00e9 syndrome","volume":"32","author":"Arcila-Londono","year":"2012","journal-title":"Semin. Neurol."},{"issue":"5","key":"10.1016\/j.yexmp.2024.104942_bb0050","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1002\/acn3.51357","article-title":"Evaluation of the EFNS\/PNS diagnostic criteria in a cohort of CIDP patients","volume":"8","author":"Athanasopoulos","year":"2021","journal-title":"Ann. Clin. Transl. Neurol."},{"issue":"1","key":"10.1016\/j.yexmp.2024.104942_bb0055","first-page":"18","article-title":"Consistency of the results of neurophysiological examinations with clinical diagnosis formed by the referring physician in ambulatory medical care","volume":"32","author":"Bembenek","year":"2023","journal-title":"Postep. Psychiatr. Neurol."},{"issue":"2","key":"10.1016\/j.yexmp.2024.104942_bb0060","first-page":"64","article-title":"A follow-up study on Guillain-Barre syndrome and validation of Brighton criteria. Iran","volume":"18","author":"Boostani","year":"2019","journal-title":"J. Neurol."},{"issue":"3","key":"10.1016\/j.yexmp.2024.104942_bb0065","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1007\/s00415-019-09634-0","article-title":"Cerebrospinal fluid total protein in Guillain-Barr\u00e9 syndrome variants: correlations with clinical category, severity, and electrophysiology","volume":"267","author":"Bourque","year":"2020","journal-title":"J. Neurol."},{"issue":"3","key":"10.1016\/j.yexmp.2024.104942_bb0070","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1007\/s13311-022-01222-x","article-title":"Therapeutic monoclonal antibody therapies in chronic autoimmune demyelinating neuropathies","volume":"19","author":"Briani","year":"2022","journal-title":"Neurotherapeutics"},{"issue":"6","key":"10.1016\/j.yexmp.2024.104942_bb0075","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1111\/ene.14796","article-title":"Misdiagnosis and diagnostic pitfalls of chronic inflammatory demyelinating polyradiculoneuropathy","volume":"28","author":"Broers","year":"2021","journal-title":"Eur. J. Neurol."},{"issue":"3","key":"10.1016\/j.yexmp.2024.104942_bb0080","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1007\/s12028-023-01707-3","article-title":"Guidelines for neuroprognostication in adults with Guillain-Barr\u00e9 syndrome","volume":"38","author":"Busl","year":"2023","journal-title":"Neurocrit. Care."},{"issue":"4","key":"10.1016\/j.yexmp.2024.104942_bb0085","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1080\/13506129.2022.2147636","article-title":"Amyloid nomenclature 2022: update, novel proteins, and recommendations by the International Society of Amyloidosis (ISA) nomenclature committee","volume":"29","author":"Buxbaum","year":"2022","journal-title":"Amyloid"},{"issue":"2","key":"10.1016\/j.yexmp.2024.104942_bb0090","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1529-8027.2011.00331.x","article-title":"Variable presentations of TTR-related familial amyloid polyneuropathy in seventeen patients","volume":"16","author":"Cappellari","year":"2011","journal-title":"J. Peripher. Nerv. Syst."},{"issue":"6","key":"10.1016\/j.yexmp.2024.104942_bb0095","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1136\/practneurol-2020-002837","article-title":"Paraproteinaemic neuropathy: MGUS and beyond","volume":"21","author":"Carroll","year":"2021","journal-title":"Pract. Neurol."},{"issue":"5","key":"10.1016\/j.yexmp.2024.104942_bb0100","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.mayocp.2017.02.003","article-title":"Monoclonal Gammopathy-associated peripheral neuropathy: diagnosis and management","volume":"92","author":"Chaudhry","year":"2017","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.yexmp.2024.104942_bb0105","article-title":"Chronic inflammatory demyelinating polyradiculoneuropathy in association With concomitant diseases: identification and management","volume":"13","author":"Chen","year":"2022","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.yexmp.2024.104942_bb0110","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1007\/s13311-021-01108-4","article-title":"Update on intravenous immunoglobulin in neurology: modulating neuro-autoimmunity, evolving factors on efficacy and dosing and challenges on stopping chronic IVIg therapy","volume":"18","author":"Dalakas","year":"2021","journal-title":"Neurotherapeutics"},{"issue":"5","key":"10.1016\/j.yexmp.2024.104942_bb0115","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1002\/mus.24226","article-title":"Sural sparing pattern discriminates Guillain-Barr\u00e9 syndrome from its mimics","volume":"50","author":"Derksen","year":"2014","journal-title":"Muscle Nerve"},{"issue":"2","key":"10.1016\/j.yexmp.2024.104942_bb0120","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/mus.21480","article-title":"Clinical and electrophysiological parameters distinguishing acute-onset chronic inflammatory demyelinating polyneuropathy from acute inflammatory demyelinating polyneuropathy","volume":"41","author":"Dionne","year":"2010","journal-title":"Muscle Nerve"},{"issue":"12","key":"10.1016\/j.yexmp.2024.104942_bb0125","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1136\/jnnp-2022-329357","article-title":"Comparison of the diagnostic accuracy of the 2021 EAN\/PNS and 2010 EFNS\/PNS diagnostic criteria for chronic inflammatory demyelinating polyradiculoneuropathy","volume":"93","author":"Doneddu","year":"2022","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"8","key":"10.1016\/j.yexmp.2024.104942_bb0130","doi-asserted-by":"crossref","first-page":"766","DOI":"10.3390\/jpm11080766","article-title":"Correlations between electrophysiological parameters, lymphocyte distribution and cytokine levels in patients with chronic demyelinating inflammatory polyneuropathy","volume":"11","author":"Dziadkowiak","year":"2021","journal-title":"J. Pers. Med."},{"issue":"2023","key":"10.1016\/j.yexmp.2024.104942_bb0135","first-page":"2305163","article-title":"miR-31-5p as a potential circulating biomarker and tracer of clinical improvement for chronic inflammatory demyelinating polyneuropathy","author":"Dziadkowiak","year":"2023","journal-title":"Oxidative Med. Cell. Longev."},{"issue":"11","key":"10.1016\/j.yexmp.2024.104942_bb0140","doi-asserted-by":"crossref","first-page":"9180","DOI":"10.3390\/ijms24119180","article-title":"Molecular, electrophysiological, and ultrasonographic differences in selected immune-mediated neuropathies with therapeutic implications","volume":"24","author":"Dziadkowiak","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.yexmp.2024.104942_bb0145","doi-asserted-by":"crossref","first-page":"3214","DOI":"10.1093\/brain\/awaa265","article-title":"Diagnostic challenges in chronic inflammatory demyelinating polyradiculoneuropathy","volume":"143","author":"Eftimov","year":"2020","journal-title":"Brain"},{"key":"10.1016\/j.yexmp.2024.104942_bb0150","doi-asserted-by":"crossref","DOI":"10.1136\/practneurol-2021-002960","article-title":"Nodal and paranodal antibody-associated neuropathies","author":"Fehmi","year":"2021","journal-title":"Pract. Neurol."},{"key":"10.1016\/j.yexmp.2024.104942_bb0155","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s42466-020-00088-8","article-title":"Comprehensive approaches for diagnosis, monitoring and treatment of chronic inflammatory demyelinating polyneuropathy","volume":"2","author":"Fisse","year":"2020","journal-title":"Neurol. Res. Pract."},{"issue":"15","key":"10.1016\/j.yexmp.2024.104942_bb0160","doi-asserted-by":"crossref","first-page":"5009","DOI":"10.3390\/jcm12155009","article-title":"Nerve MR in the differential diagnosis of neuropathies: A case series from a single center","volume":"12","author":"Giordano","year":"2023","journal-title":"J. Clin. Med."},{"issue":"1","key":"10.1016\/j.yexmp.2024.104942_bb0165","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s13760-018-01069-0","article-title":"Transthyretin familial amyloid polyneuropathy due to lle107Val mutation mimicking atypical chronic inflammatory demyelinating polyneuropathy: case report","volume":"120","author":"Gondim","year":"2020","journal-title":"Acta Neurol. Belg."},{"issue":"2","key":"10.1016\/j.yexmp.2024.104942_bb0170","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1016\/j.clinph.2015.06.032","article-title":"Ultrasound and electrophysiologic findings in patients with Guillain-Barr\u00e9 syndrome at disease onset and over a period of six months","volume":"127","author":"Grimm","year":"2016","journal-title":"Clin. Neurophysiol."},{"issue":"3","key":"10.1016\/j.yexmp.2024.104942_bb0175","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1007\/s13311-019-00716-5","article-title":"Differentiation between Guillain-Barr\u00e9 Syndrome and acute-onset chronic inflammatory demyelinating polyradiculoneuritis-a prospective follow-up study using ultrasound and neurophysiological measurements","volume":"16","author":"Grimm","year":"2019","journal-title":"Neurotherapeutics"},{"issue":"5","key":"10.1016\/j.yexmp.2024.104942_bb0180","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/mus.27803","article-title":"Changes in electrophysiological findings suggestive of demyelination following Guillain-Barr\u00e9 syndrome: A retrospective study","volume":"67","author":"Gu\u00e9my","year":"2023","journal-title":"Muscle Nerve"},{"issue":"4","key":"10.1016\/j.yexmp.2024.104942_bb0185","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s12098-018-2835-5","article-title":"How different is AMAN from AIDP in childhood GBS? A prospective study from North India","volume":"86","author":"Gupta","year":"2019","journal-title":"Indian J. Pediatr."},{"issue":"5","key":"10.1016\/j.yexmp.2024.104942_bb0190","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s11910-023-01264-4","article-title":"Growing spectrum of autoimmune nodopathies","volume":"23","author":"Gupta","year":"2023","journal-title":"Curr. Neurol. Neurosci. Rep."},{"issue":"5","key":"10.1016\/j.yexmp.2024.104942_bb0195","first-page":"1327","article-title":"Guillain-Barr\u00e9 Syndrome","volume":"29","author":"Habib","year":"2023","journal-title":"Continuum (Minneap Minn)."},{"issue":"2","key":"10.1016\/j.yexmp.2024.104942_bb0200","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/jns.12547","article-title":"IgM anti-MAG\u00b1 peripheral neuropathy (IMAGiNe) study protocol: an international, observational, prospective registry of patients with IgM M-protein peripheral neuropathies","volume":"28","author":"Hamadeh","year":"2023","journal-title":"J. Peripher. Nerv. Syst."},{"issue":"9","key":"10.1016\/j.yexmp.2024.104942_bb0205","first-page":"CD002063","article-title":"Intravenous immunoglobulin for Guillain-Barr\u00e9 syndrome","volume":"2014","author":"Hughes","year":"2014","journal-title":"Cochrane Database Syst. Rev."},{"issue":"10","key":"10.1016\/j.yexmp.2024.104942_bb0210","article-title":"Corticosteroids for Guillain-Barr\u00e9 syndrome","volume":"10","author":"Hughes","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.yexmp.2024.104942_bb0215","doi-asserted-by":"crossref","DOI":"10.1007\/s13760-024-02557-2","article-title":"Differentiating recurrent Guillain-Barre syndrome and acute-onset chronic inflammatory polyneuropathy: literature review","author":"Inan","year":"2024","journal-title":"Acta Neurol. Belg."},{"issue":"8","key":"10.1016\/j.yexmp.2024.104942_bb0220","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.clml.2023.04.008","article-title":"POEMS Syndrome-clinical picture and management. Current Knowledge","volume":"23","author":"Jurczyszyn","year":"2023","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"key":"10.1016\/j.yexmp.2024.104942_bb0225","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/978-981-32-9636-7_20","article-title":"Guillain-Barr\u00e9 Syndrome","volume":"1190","author":"Kaida","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"issue":"6","key":"10.1016\/j.yexmp.2024.104942_bb0230","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.4103\/aian.aian_382_22","article-title":"Nodo-paranodopathies: concepts, clinical implications, and management","volume":"25","author":"Khadilkar","year":"2022","journal-title":"Ann. Indian Acad. Neurol."},{"issue":"1","key":"10.1016\/j.yexmp.2024.104942_bb0235","doi-asserted-by":"crossref","first-page":"14000","DOI":"10.1038\/s41598-023-41072-x","article-title":"Early electrophysiological study variants and their relationship with clinical presentation and outcomes of patients with Guillain-Barr\u00e9 syndrome","volume":"13","author":"Khedr","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.yexmp.2024.104942_bb0240","first-page":"543","article-title":"A rare case with new insights: pure sensory Guillain Barre Syndrome with axonal features","volume":"13","author":"Kofahi","year":"2020","journal-title":"Int. Med. Case Rep. J."},{"issue":"2","key":"10.1016\/j.yexmp.2024.104942_bb0245","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s40120-020-00190-8","article-title":"Pathophysiology of chronic inflammatory demyelinating polyneuropathy: insights into classification and therapeutic strategy","volume":"9","author":"Koike","year":"2020","journal-title":"Neurol. Ther."},{"issue":"23","key":"10.1016\/j.yexmp.2024.104942_bb0250","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1212\/WNL.0000000000006625","article-title":"Ultrastructural mechanisms of macrophage-induced demyelination in CIDP","volume":"91","author":"Koike","year":"2018","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.yexmp.2024.104942_bb0255","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1136\/jnnp-2019-322479","article-title":"Ultrastructural mechanisms of macrophage-induced demyelination in Guillain-Barr\u00e9 syndrome","volume":"91","author":"Koike","year":"2020","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"4","key":"10.1016\/j.yexmp.2024.104942_bb0260","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.clinph.2020.01.013","article-title":"Electrophysiological features of chronic inflammatory demyelinating polyradiculoneuropathy associated with IgG4 antibodies targeting neurofascin 155 or contactin 1 glycoproteins","volume":"131","author":"Kouton","year":"2020","journal-title":"Clin. Neurophysiol."},{"issue":"2","key":"10.1016\/j.yexmp.2024.104942_bb0265","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3390\/diagnostics11020211","article-title":"Nerve ultrasound as helpful tool in polyneuropathies","volume":"11","author":"Kramer","year":"2021","journal-title":"Diagnostics (Basel)."},{"issue":"7","key":"10.1016\/j.yexmp.2024.104942_bb0270","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1007\/s00415-017-8543-7","article-title":"Large coverage MR neurography in CIDP: diagnostic accuracy and electrophysiological correlation","volume":"264","author":"Kronlage","year":"2017","journal-title":"J. Neurol."},{"issue":"1","key":"10.1016\/j.yexmp.2024.104942_bb0275","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1097\/WNO.0000000000001700","article-title":"Vision loss as a presenting feature of chronic inflammatory demyelinating polyneuropathy: A case series","volume":"43","author":"Kruszewski","year":"2023","journal-title":"J. Neuroophthalmol."},{"issue":"8","key":"10.1016\/j.yexmp.2024.104942_bb0280","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/nrneurol.2014.117","article-title":"Diagnosis and treatment of chronic acquired demyelinating polyneuropathies","volume":"10","author":"Latov","year":"2014","journal-title":"Nat. Rev. Neurol."},{"issue":"4","key":"10.1016\/j.yexmp.2024.104942_bb0285","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1007\/s13760-023-02215-z","article-title":"Genetic screening for transthyretin familial amyloid polyneuropathy to avoid misdiagnosis in patients with polyneuropathy associated with high protein in the cerebrospinal fluid","volume":"123","author":"Lorenzoni","year":"2023","journal-title":"Acta Neurol. Belg."},{"issue":"2","key":"10.1016\/j.yexmp.2024.104942_bb0290","doi-asserted-by":"crossref","first-page":"e143","DOI":"10.1212\/WNL.0000000000005777","article-title":"Transthyretin amyloid polyneuropathies mimicking a demyelinating polyneuropathy","volume":"91","author":"Lozeron","year":"2018","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.yexmp.2024.104942_bb0295","first-page":"CD003280","article-title":"Immunomodulatory treatment other than corticosteroids, immunoglobulin and plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy","volume":"5","author":"Mahdi-Rogers","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"issue":"1","key":"10.1016\/j.yexmp.2024.104942_bb0300","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/mus.22229","article-title":"Amyloid neuropathy mimicking chronic inflammatory demyelinating polyneuropathy","volume":"45","author":"Mathis","year":"2012","journal-title":"Muscle Nerve"},{"issue":"7","key":"10.1016\/j.yexmp.2024.104942_bb0305","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.3390\/diagnostics12071691","article-title":"Relevance of nerve biopsy in the diagnosis of chronic inflammatory demyelinating polyneuropathy-A systematic review","volume":"12","author":"Moise","year":"2022","journal-title":"Diagnostics (Basel)."},{"key":"10.1016\/j.yexmp.2024.104942_bb0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2020.135595","article-title":"New evidence for secondary axonal degeneration in demyelinating neuropathies","volume":"744","author":"Moss","year":"2021","journal-title":"Neurosci. Lett."},{"issue":"5","key":"10.1016\/j.yexmp.2024.104942_bb0315","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1002\/mus.26804","article-title":"Rituximab in refractory chronic inflammatory demyelinating polyneuropathy","volume":"61","author":"Muley","year":"2020","journal-title":"Muscle Nerve"},{"issue":"2","key":"10.1016\/j.yexmp.2024.104942_bb0320","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/mus.27918","article-title":"Sensitivity and specificity of phrenic nerve electrophysiology to predict mechanical ventilation in the Guillain-Barr\u00e9 syndrome","volume":"68","author":"Naresh","year":"2023","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.yexmp.2024.104942_bb0325","doi-asserted-by":"crossref","first-page":"1250774","DOI":"10.3389\/fneur.2023.1250774","article-title":"Miller Fisher syndrome: an updated narrative review","volume":"14","author":"Noioso","year":"2023","journal-title":"Front. Neurol."},{"issue":"1","key":"10.1016\/j.yexmp.2024.104942_bb0330","article-title":"Treatments for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): an overview of systematic reviews","volume":"1","author":"Oaklander","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"issue":"1","key":"10.1016\/j.yexmp.2024.104942_bb0335","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1136\/practneurol-2021-003070","article-title":"Chronic immune sensory polyradiculopathy (CISP)","volume":"22","author":"Ong","year":"2022","journal-title":"Pract. Neurol."},{"key":"10.1016\/j.yexmp.2024.104942_bb0340","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.cnp.2022.09.001","article-title":"Sural-sparing pattern: A study against electrodiagnostic subtypes of Guillain-Barr\u00e9 syndrome","volume":"7","author":"Pasutharnchat","year":"2022","journal-title":"Clin. Neurophysiol. Pract."},{"issue":"4","key":"10.1016\/j.yexmp.2024.104942_bb0345","doi-asserted-by":"crossref","first-page":"399","DOI":"10.7861\/clinmedicine.10-4-399","article-title":"Guillain-Barr\u00e9 syndrome","volume":"10","author":"Pritchard","year":"2010","journal-title":"Clin. Med. (Lond.)"},{"issue":"4","key":"10.1016\/j.yexmp.2024.104942_bb0350","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1007\/s13311-021-01117-3","article-title":"Novel immunological and therapeutic insights in Guillain-Barr\u00e9 Syndrome and CIDP","volume":"18","author":"Querol","year":"2021","journal-title":"Neurotherapeutics"},{"issue":"2","key":"10.1016\/j.yexmp.2024.104942_bb0355","first-page":"496","article-title":"Association of CSF total protein with clinical heterogeneity, disease severity and electrophysiological pattern in GBS patients","volume":"33","author":"Rahaman","year":"2024","journal-title":"Mymensingh Med. J."},{"issue":"3","key":"10.1016\/j.yexmp.2024.104942_bb0360","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1007\/s13311-022-01253-4","article-title":"Immunoglobulin and monoclonal antibody therapies in Guillain-Barr\u00e9 Syndrome","volume":"19","author":"Rajabally","year":"2022","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.yexmp.2024.104942_bb0365","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2147\/ITT.S388151","article-title":"Chronic inflammatory demyelinating polyradiculoneuropathy: current therapeutic approaches and future outlooks","volume":"13","author":"Rajabally","year":"2024","journal-title":"Immunotargets Ther."},{"issue":"21","key":"10.1016\/j.yexmp.2024.104942_bb0370","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1212\/WNL.0b013e3181e07d14","article-title":"Distinguishing acute-onset CIDP from fluctuating Guillain-Barr\u00e9 syndrome: a prospective study","volume":"74","author":"Ruts","year":"2010","journal-title":"Neurology"},{"issue":"10280","key":"10.1016\/j.yexmp.2024.104942_bb0375","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/S0140-6736(21)00517-1","article-title":"Guillain-Barr\u00e9 syndrome","volume":"397","author":"Shahrizaila","year":"2021","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.yexmp.2024.104942_bb0380","doi-asserted-by":"crossref","first-page":"7288","DOI":"10.3390\/ijms24087288","article-title":"Immune-mediated neuropathies: pathophysiology and management","volume":"24","author":"Shastri","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"16","key":"10.1016\/j.yexmp.2024.104942_bb0385","doi-asserted-by":"crossref","first-page":"e2078","DOI":"10.1212\/WNL.0000000000011792","article-title":"Expanding the Spectrum of chronic immune sensory Polyradiculopathy: CISP-plus","volume":"96","author":"Shelly","year":"2021","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.yexmp.2024.104942_bb0390","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/mus.27046","article-title":"Chronic inflammatory demyelinating polyradiculoneuropathy-diagnostic pitfalls and treatment approach","volume":"63","author":"Stino","year":"2021","journal-title":"Muscle Nerve"},{"issue":"3","key":"10.1016\/j.yexmp.2024.104942_bb0395","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/jns.12398","article-title":"Diagnosis of Guillain-Barr\u00e9 syndrome and validation of the Brighton criteria in Malaysia","volume":"25","author":"Tan","year":"2020","journal-title":"J. Peripher. Nerv. Syst."},{"issue":"Suppl. 3","key":"10.1016\/j.yexmp.2024.104942_bb0400","first-page":"S23","article-title":"Autoimmune nodo-paranodopathies 10years later: clinical features, pathophysiology and treatment","volume":"28","author":"Uncini","year":"2023","journal-title":"J. Peripher. Nerv. Syst."},{"issue":"11","key":"10.1016\/j.yexmp.2024.104942_bb0405","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1136\/jnnp-2014-310097","article-title":"Nodopathies of the peripheral nerve: an emerging concept","volume":"86","author":"Uncini","year":"2015","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.yexmp.2024.104942_bb0410","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.902172","article-title":"Nodopathies in the early diagnosis of axonal forms of Guillain-Barr\u00e9 Syndrome","volume":"13","author":"Urdiales-S\u00e1nchez","year":"2022","journal-title":"Front. Neurol."},{"issue":"8","key":"10.1016\/j.yexmp.2024.104942_bb0415","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nrneurol.2014.121","article-title":"Guillain-Barr\u00e9 syndrome: pathogenesis, diagnosis, treatment and prognosis","volume":"10","author":"van den Berg","year":"2014","journal-title":"Nat. Rev. Neurol."},{"issue":"11","key":"10.1016\/j.yexmp.2024.104942_bb0420","doi-asserted-by":"crossref","first-page":"3556","DOI":"10.1111\/ene.14959","article-title":"European academy of neurology\/peripheral nerve society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force-second revision","volume":"28","author":"Van den Bergh","year":"2021","journal-title":"Eur. J. Neurol."},{"issue":"12","key":"10.1016\/j.yexmp.2024.104942_bb0425","doi-asserted-by":"crossref","first-page":"3646","DOI":"10.1111\/ene.16073","article-title":"European academy of neurology\/peripheral nerve society guideline on diagnosis and treatment of Guillain-Barr\u00e9 syndrome","volume":"30","author":"van Doorn","year":"2023","journal-title":"Eur. J. Neurol."},{"issue":"2","key":"10.1016\/j.yexmp.2024.104942_bb0430","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1136\/jnnp-2019-321496","article-title":"Original research: second IVIg course in Guillain-Barr\u00e9 syndrome with poor prognosis: the non-randomised ISID study","volume":"91","author":"Verboon","year":"2020","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"4","key":"10.1016\/j.yexmp.2024.104942_bb0435","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S1474-4422(20)30494-4","article-title":"Second intravenous immunoglobulin dose in patients with Guillain-Barr\u00e9 syndrome with poor prognosis (SID-GBS): a double-blind, randomised, placebo-controlled trial","volume":"20","author":"Walgaard","year":"2021","journal-title":"Lancet Neurol."},{"issue":"10045","key":"10.1016\/j.yexmp.2024.104942_bb0440","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0140-6736(16)00339-1","article-title":"Guillain-Barr\u00e9 syndrome","volume":"388","author":"Willison","year":"2016","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.yexmp.2024.104942_bb0445","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.3892\/etm.2014.1955","article-title":"Pure sensory Guillain-Barr\u00e9 syndrome: A case report and review of the literature","volume":"8","author":"Yang","year":"2014","journal-title":"Exp. Ther. Med."},{"issue":"8","key":"10.1016\/j.yexmp.2024.104942_bb0450","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1007\/s00381-010-1197-8","article-title":"Magnetic resonance imaging of childhood Guillain-Barre syndrome","volume":"26","author":"Yikilmaz","year":"2010","journal-title":"Childs Nerv. Syst."}],"container-title":["Experimental and Molecular Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014480024000613?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014480024000613?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,16]],"date-time":"2024-12-16T21:51:09Z","timestamp":1734385869000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014480024000613"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":90,"alternative-id":["S0014480024000613"],"URL":"https:\/\/doi.org\/10.1016\/j.yexmp.2024.104942","relation":{},"ISSN":["0014-4800"],"issn-type":[{"value":"0014-4800","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnostic criteria and therapeutic implications of rapid-onset demyelinating polyneuropathies","name":"articletitle","label":"Article Title"},{"value":"Experimental and Molecular Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexmp.2024.104942","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"104942"}}